United Therapeutics (UTHR) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free UTHR Stock Alerts $233.85 -2.10 (-0.89%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplantfinance.yahoo.com - April 26 at 4:17 PMCORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplantbusinesswire.com - April 26 at 2:02 PMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares of Stockamericanbankingnews.com - April 26 at 6:58 AMUnited Therapeutics Reports First Successful Xenothymokidney Transplantmarketwatch.com - April 26 at 6:16 AMInsider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells 3,600 Shares of Stockinsidertrades.com - April 26 at 5:52 AMMartine A. Rothblatt Sells 3,600 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stockmarketbeat.com - April 25 at 7:40 PMUnited Therapeutics (UTHR) Scheduled to Post Earnings on Wednesdaymarketbeat.com - April 25 at 11:45 AMPoplar Forest Capital LLC Sells 59,914 Shares of United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 25 at 12:14 AMLatest pig organ transplant in human marks milestone for Maryland companybizjournals.com - April 24 at 6:02 PMUnited Therapeutics Announces World’s First Successful Xenothymokidney Transplantfinance.yahoo.com - April 24 at 12:57 PMUnited Therapeutics Announces World's First Successful Xenothymokidney Transplantbusinesswire.com - April 24 at 9:00 AMUnited Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024businesswire.com - April 24 at 7:00 AMUnited Therapeutics Co. (NASDAQ:UTHR) Receives Average Rating of "Moderate Buy" from Analystsamericanbankingnews.com - April 24 at 2:48 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Sharesmarketbeat.com - April 23 at 6:40 PMDuality Advisers LP Acquires 5,622 Shares of United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 23 at 7:52 AMZurcher Kantonalbank Zurich Cantonalbank Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 22 at 5:48 AMUnited Therapeutics CEO Martine Rothblatt sells $1.7m in stockinvesting.com - April 21 at 3:02 PMUnited Therapeutics Corporation (UTHR)finance.yahoo.com - April 21 at 3:02 PMUnited Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Vontobel Holding Ltd.marketbeat.com - April 21 at 5:24 AMInternational Assets Investment Management LLC Increases Holdings in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 20 at 4:42 AMLeerink Partnrs Brokers Cut Earnings Estimates for United Therapeutics Co. (NASDAQ:UTHR)americanbankingnews.com - April 20 at 2:42 AMLeerink Partnrs Comments on United Therapeutics Co.'s FY2024 Earnings (NASDAQ:UTHR)marketbeat.com - April 19 at 8:50 AMUnited Therapeutics: Strategic Expansion and Competitive Edge Reinforce Outperform Ratingmarkets.businessinsider.com - April 18 at 8:23 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Sells $835,380.00 in Stockinsidertrades.com - April 18 at 6:16 AMUnited Therapeutics Co. (NASDAQ:UTHR) to Post Q1 2024 Earnings of $5.93 Per Share, Leerink Partnrs Forecastsamericanbankingnews.com - April 18 at 5:48 AMUnited Therapeutics CEO Martine Rothblatt sells shares worth over $1.7 millioninvesting.com - April 16 at 11:57 PMUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conferencefinance.yahoo.com - April 16 at 8:55 AMLouisiana State Employees Retirement System Makes New $2.90 Million Investment in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 16 at 6:51 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Sells $847,512.00 in Stockinsidertrades.com - April 16 at 4:19 AMMartine A. Rothblatt Sells 13,800 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stockinsidertrades.com - April 13 at 4:54 AMInnovation in Healthcare: HTEC’s Q1 2024 Index Rebalancefinance.yahoo.com - April 12 at 3:30 PMUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Allspring Global Investments Holdings LLCmarketbeat.com - April 12 at 6:18 AMUnited Therapeutics (NASDAQ:UTHR) Downgraded by StockNews.com to "Buy"marketbeat.com - April 11 at 11:12 PMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 13,800 Sharesmarketbeat.com - April 11 at 6:34 PMUnited Therapeutics chairperson & CEO sells $4.73m in stockinvesting.com - April 11 at 1:41 PMInsider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells 5,060 Shares of Stockinsidertrades.com - April 10 at 4:53 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Sells $1,201,851.20 in Stockmarketbeat.com - April 9 at 6:30 PMUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Tobammarketbeat.com - April 9 at 11:47 AMDekaBank Deutsche Girozentrale Boosts Holdings in United Therapeutics Co. (NASDAQ:UTHR)marketbeat.com - April 8 at 7:13 AMUnited Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 15,000 Sharesinsidertrades.com - April 8 at 4:24 AMUnited Therapeutics EVP sells over $1.3m in company stockinvesting.com - April 6 at 4:01 PMInsider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ...finance.yahoo.com - April 6 at 9:54 AMInsider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells 15,000 Shares of Stockinsidertrades.com - April 6 at 7:31 AMUnited Therapeutics Co. (NASDAQ:UTHR) EVP Sells $1,394,220.00 in Stockinsidertrades.com - April 5 at 7:18 AMUnited Therapeutics Co. (NASDAQ:UTHR) EVP Paul A. Mahon Sells 6,000 Sharesmarketbeat.com - April 4 at 7:07 PM3 Underappreciated Healthcare Stocks to Buy Now: April 2024investorplace.com - April 3 at 8:02 PMUnited Therapeutics (NASDAQ:UTHR) Upgraded at StockNews.commarketbeat.com - April 3 at 2:17 AMUnited Therapeutics motion for restraining order over Liquidia's Yutrepia deniedmsn.com - March 31 at 8:59 AMUnited Therapeutics Co. (NASDAQ:UTHR) Shares Sold by SG Americas Securities LLCmarketbeat.com - March 31 at 4:15 AMInsider Selling: United Therapeutics Co. (NASDAQ:UTHR) Director Sells 325 Shares of Stockinsidertrades.com - March 30 at 7:38 AM Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. UTHR Media Mentions By Week UTHR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼0.620.32▲Average Medical News Sentiment UTHR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼266▲UTHR Articles Average Week Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IONS News BMRN News MDGL News ALKS News ALNY News FOLD News SRPT News CTLT News RDY News KRTX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
